Skip to main content
. Author manuscript; available in PMC: 2014 Feb 4.
Published in final edited form as: Mol Pharm. 2013 Jan 14;10(2):709–716. doi: 10.1021/mp300507r

Figure 5.

Figure 5

Biodistribution of 64Cu-NOTA-TRC105-F(ab')2, or 64Cu-NOTA-TRC105-F(ab')2 after a blocking dose of TRC105, in 4T1 tumor-bearing mice at 3 h (A) or 48 h (B) post-injection. n = 4; *, P < 0.05.